Findings

What do systematic reviews say?

4,703 questions · 15,007 findings · 1,416 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2,881 · 19.2%GRADE not reported 1,551 · 10.3%Very low 3,111 · 20.7%Low 3,881 · 25.9%Moderate 2,669 · 17.8%High 914 · 6.1%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Summary of findings table ‐ Sucrose (any concentration, any dose, with or without NNS) vs placebo or control

PIPP ‐ Preterm infants · neonates

1 finding from 1 review

Sucrose analgesia for heel‐lance procedures in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 192 participants
Low

Summary of findings table ‐ Sucrose (any concentration, any dose, with or without NNS) vs placebo or control

DAN scores at 30 seconds after heel lancing (term infants)Scale from: 0 to 10 · neonates

1 finding from 1 review

Sucrose analgesia for heel‐lance procedures in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 32 participants
Very low

Summary of findings table ‐ Sucrose (any concentration, any dose, with or without NNS) vs placebo or control

Neonatal Infant Pain Scale (NIPS) · neonates

1 finding from 1 review

Sucrose analgesia for heel‐lance procedures in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 56 participants
Moderate

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

Fatigue · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

Functional capacity · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

Pain (SF‐36 Bodily Pain domain, score 0‐100, lower scores indicate less pain) · systemic lupus erythematosus

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 17 participants
Low

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

Disease activity ‐ not measured · systemic lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

Quality of life ‐ not measured · systemic lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

Serious adverse events ‐ not reported · systemic lupus erythematosus

The review found no eligible studies for this question.

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

Withdrawals due to any reason · systemic lupus erythematosus

It is very uncertain whether summary of findings table ‐ Exercise plus usual pharmacological care changes withdrawals due to any reason compared with placebo plus usual pharmacological care (very low certainty).

1 finding from 1 review

Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
RR 2.73 [0.34, 22.16]
1 study · 21 participants
Very low

Tramadol vs no treatment or placebo

Pain · postoperative pain in preterm and term infants

The review found no eligible studies for this question.

1 finding from 1 review

Systemic opioids versus other analgesics and sedatives for postoperative pain in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tramadol vs no treatment or placebo

Major neurodevelopmental disability in children aged 18 to 24 months CA · postoperative pain in preterm and term infants

The review found no eligible studies for this question.

1 finding from 1 review

Systemic opioids versus other analgesics and sedatives for postoperative pain in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tramadol vs no treatment or placebo

Major neurodevelopmental disability in children aged 3 to 5 years CA · postoperative pain in preterm and term infants

The review found no eligible studies for this question.

1 finding from 1 review

Systemic opioids versus other analgesics and sedatives for postoperative pain in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tramadol vs no treatment or placebo

Cognitive and educational outcomes in children more than five years old · postoperative pain in preterm and term infants

The review found no eligible studies for this question.

1 finding from 1 review

Systemic opioids versus other analgesics and sedatives for postoperative pain in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tramadol vs no treatment or placebo

All‐cause mortality during hospital stay · postoperative pain in preterm and term infants

It is very uncertain whether tramadol changes all‐cause mortality during initial hospitalization compared with no treatment or placebo (very low certainty).

1 finding from 1 review

Systemic opioids versus other analgesics and sedatives for postoperative pain in neonates 2023 · Cochrane Headline outcomes only
RR 0.32 [0.01, 7.7]
1 study · 71 participants
Very low

Tramadol vs no treatment or placebo

Severe (defined as stage 3 or greater) retinopathy of prematurity ‐ not reported · postoperative pain in preterm and term infants

The review found no eligible studies for this question.

1 finding from 1 review

Systemic opioids versus other analgesics and sedatives for postoperative pain in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Tramadol vs no treatment or placebo

Severe (grade 3 or greater) intraventricular hemorrhage (IVH) on cranial ultrasound ‐ not reported · postoperative pain in preterm and term infants

The review found no eligible studies for this question.

1 finding from 1 review

Systemic opioids versus other analgesics and sedatives for postoperative pain in neonates 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis‐based medicines vs placebo medication

Proportion of participants reporting no worse than mild pain by 14 days after start of treatment · adults with cancer‐related pain

The review found no eligible studies for this question.

1 finding from 1 review

Cannabis‐based medicines and medical cannabis for adults with cancer pain 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cannabis‐based medicines vs placebo medication

Patient Global Impression of Change much or very much improved · adults with cancer‐related pain

Cannabis‐based medicines probably leads to higher PGIC of much improved or very much improved compared with placebo medication (moderate certainty).

1 finding from 1 review

Cannabis‐based medicines and medical cannabis for adults with cancer pain 2023 · Cochrane Headline outcomes only
RD 0.06 [0.01, 0.12]
3 studies · 996 participants
Moderate

Cannabis‐based medicines vs placebo medication

Withdrawals due to adverse events · adults with cancer‐related pain

Cannabis‐based medicines showed no clear difference in withdrawals due to adverse events compared with placebo medication (moderate certainty).

1 finding from 1 review

Cannabis‐based medicines and medical cannabis for adults with cancer pain 2023 · Cochrane Headline outcomes only
RD 0.04 [0, 0.08]
4 studies · 1332 participants
Moderate